|
Virbac - Company Profile Snapshot
| Company Profile: |
Virbac |
| Ticker: |
VIR |
| Exchanges: |
PAR |
| 2008 Sales: |
443,360,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Miscellaneous Companies |
| Country: |
FRANCE |
| Employees: |
2880 |
Business Description
Virbac. The Group's principal activities are the research, development, manufacture and distribution of veterinary drugs including antibiotics, anti-parasitic drugs, vaccines and dermatological drugs dedicated to animal health care. Their activities are carried out in the following sectors: Pets, Food Producing Animals and other related activities. The Group operates under the brand names Rilexin, Humigel, Novifit, Vet Aquadent, Tenotryl, Megaderm and Anxitan. The Group has operations accross the globe. In 2008, the Group acquired Pharmalett and Schering ranges.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
